UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
CHA Biotech revises separate operating profit to a loss in 2018
by Jeong Sae-im
2019-03-15 16:26
'OliX to target global market with RNA technology'
by Lee Han-soo
2019-03-15 11:44
Loss-making Medipost seeks to avoid administrative issue designation
by Jeong Sae-im
2019-03-14 14:33
Celltrion Healthcare wins biosimilar bids in SE Asia
by Lee Han-soo
2019-03-07 14:25
Biogen seeks gene therapy pipeline for rare eye disease
by Kim Yun-mi
2019-03-06 14:41
라인
Europe OKs Samsung Bioepis’ biosimilar treatment of breast cancer
by Lee Han-soo
2019-03-05 17:53
Bridge Biotherapeutics to accelerate global presence
by Lee Han-soo
2019-03-04 10:50
BioGenetics inks deal to supply biliary tract cancer drug in Korea
by Lee Hye-seon
2019-02-28 16:49
Researchers find biomarker to predict recurrence of chronic myeloid leukemia
by Park Gi-taek
2019-02-25 16:03
Celltrion Healthcare posts ₩713.5 billion in 2018 sales
by Lee Han-soo
2019-02-22 17:29
라인
Alteogen applies for P1 trial for Eylea biosimilar
by Lee Han-soo
2019-02-22 16:03
Samsung Bioepis, C-Bridge Capital to develop biosimilars in China
by Lee Han-soo
2019-02-11 11:23
Samsung BioLogics posts ₩535.8 billion in 2018 sales
by Lee Han-soo
2019-02-01 11:56
Celltrion to export biosimilars to Latin America
by Lee Han-soo
2019-01-31 11:12
Samsung Bioepis’ biosimilar sales in EU exceed $500 million
by Lee Han-soo
2019-01-30 18:17
라인
KIST finds boiling histotripsy’s mechanism to remove tumor tissue
by Cho In-sung
2019-01-24 11:30
FDA OKs Samsung Bioepis’ first oncology medicine
by Lee Han-soo
2019-01-21 11:43
Celltrion wins patent dispute on Truxima
by Lee Han-soo
2019-01-18 11:47
Over 1,000 bio-ventures set up in past 3 years
by Lee Han-soo
2019-01-17 22:05
CL Bio wins patent for substance that improves antidiabetic functions
by Lee Han-soo
2019-01-14 12:34
-
이전
11
12
13
14
15
16
17
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top